RHENMAN & PARTNERS ASSET MANAGEMENT AB Holdings

RHENMAN & PARTNERS ASSET MANAGEMENT AB is an investment fund managing more than 955.01M US dollars. The largest holdings include Eli Lilly and Company, UnitedHealth Group Incorporated and Boston Scientific. In Q3 2022 the fund bought assets of total value of 162.87M US dollars and sold assets of total value of 95.07M US dollars.

$955.01M

portfolio value

+1.38%

quarter

-5.73%

1 year

+52.72%

3 years

+62.28%

5 years

RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	34071000	176010000
Q2 2016	122840000	68429000
Q3 2016	169290796	112016003
Q4 2016	94823383	193828324
Q1 2017	155705000	50709000
Q2 2017	148896000	72787000
Q3 2017	189935000	119632000
Q4 2017	112037000	141192000
Q1 2018	142756000	79302000
Q2 2018	223007000	64359000
Q3 2018	124083000	97410000
Q4 2018	64654000	164667000
Q1 2019	116430000	140332000
Q2 2019	155356000	68118000
Q3 2019	73976000	187490000
Q4 2019	183687000	73975000
Q1 2020	-20247000	156816000
Q2 2020	157966000	48769000
Q3 2020	212033000	17525000
Q4 2020	256082000	95138000
Q1 2021	313926000	104991000
Q2 2021	225415000	198189000
Q3 2021	140489000	170074000
Q4 2021	176710000	89063000
Q1 2022	66929000	548184000
Q2 2022	76344000	190854000
Q3 2022	162873000	95073000

RHENMAN & PARTNERS ASSET MANAGEMENT AB 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Drug Manufacturers—General Eli Lilly and Company Portfolio share: 3.68% Portfolio value: 35.12M Avg. open price: $119.48 Current price: $369.29 P/L: +209.09% Bought +7.78% shares Q3 2022	share	3.68%	35.12M	$119.48	$369.29	+209.09%	Bought +7.78% shares Q3 2022
Healthcare Plans UnitedHealth Group Incorporated Portfolio share: 3.19% Portfolio value: 30.42M Avg. open price: $209.64 Current price: $535.04 P/L: +155.22% Sold -2.14% shares Q3 2022	share	3.19%	30.42M	$209.64	$535.04	+155.22%	Sold -2.14% shares Q3 2022
Medical Devices Boston Scientific Corporation Portfolio share: 3.14% Portfolio value: 29.96M Avg. open price: $40.95 Current price: $45.42 P/L: +10.91% Sold -4.14% shares Q3 2022	share	3.14%	29.96M	$40.95	$45.42	+10.91%	Sold -4.14% shares Q3 2022
Biotechnology Vertex Pharmaceuticals Incorporated Portfolio share: 3.14% Portfolio value: 29.95M Avg. open price: $169.38 Current price: $317.6 P/L: +87.51% Bought +1.05% shares Q3 2022	share	3.14%	29.95M	$169.38	$317.6	+87.51%	Bought +1.05% shares Q3 2022
Diagnostics & Research Thermo Fisher Scientific Inc. Portfolio share: 2.83% Portfolio value: 26.98M Avg. open price: $410.38 Current price: $557.21 P/L: +35.78% Bought +41.51% shares Q3 2022	share	2.83%	26.98M	$410.38	$557.21	+35.78%	Bought +41.51% shares Q3 2022
Healthcare Plans Humana Inc. Portfolio share: 2.57% Portfolio value: 24.55M Avg. open price: $294.42 Current price: $547.42 P/L: +85.93% Bought +2.33% shares Q3 2022	share	2.57%	24.55M	$294.42	$547.42	+85.93%	Bought +2.33% shares Q3 2022
Healthcare Plans CIGNA CORP NEW Portfolio share: 2.54% Portfolio value: 24.23M Avg. open price: $181.6 Current price: $327.39 P/L: +80.28% Sold -32.43% shares Q3 2022	share	2.54%	24.23M	$181.6	$327.39	+80.28%	Sold -32.43% shares Q3 2022
Biotechnology Regeneron Pharmaceuticals, Inc. Portfolio share: 2.51% Portfolio value: 23.96M Avg. open price: $456.74 Current price: $755.45 P/L: +65.40% Bought +128.57% shares Q3 2022	share	2.51%	23.96M	$456.74	$755.45	+65.40%	Bought +128.57% shares Q3 2022
Drug Manufacturers—General AbbVie Inc. Portfolio share: 2.29% Portfolio value: 21.90M Avg. open price: $78.04 Current price: $163.96 P/L: +110.11% Sold -21.25% shares Q3 2022	share	2.29%	21.90M	$78.04	$163.96	+110.11%	Sold -21.25% shares Q3 2022
Healthcare Plans Elevance Health Inc. Portfolio share: 2.29% Portfolio value: 21.87M Avg. open price: $491.22 Current price: $522.34 P/L: +6.34% Sold -29.82% shares Q3 2022	share	2.29%	21.87M	$491.22	$522.34	+6.34%	Sold -29.82% shares Q3 2022
Drug Manufacturers—General Merck & Co., Inc. Portfolio share: 2.28% Portfolio value: 21.75M Avg. open price: $69.47 Current price: $110.01 P/L: +58.36% Sold -18.87% shares Q3 2022	share	2.28%	21.75M	$69.47	$110.01	+58.36%	Sold -18.87% shares Q3 2022
Medical Devices Abiomed, Inc. Portfolio share: 2.27% Portfolio value: 21.65M Avg. open price: $249.98 Current price: $378.26 P/L: +51.32% Bought +17.67% shares Q3 2022	share	2.27%	21.65M	$249.98	$378.26	+51.32%	Bought +17.67% shares Q3 2022
Medical Distribution AmerisourceBergen Corporation Portfolio share: 2.24% Portfolio value: 21.38M Avg. open price: $91.64 Current price: $171.25 P/L: +86.87% Bought +8.80% shares Q3 2022	share	2.24%	21.38M	$91.64	$171.25	+86.87%	Bought +8.80% shares Q3 2022
Healthcare Plans CVS Health Corporation Portfolio share: 2.23% Portfolio value: 21.30M Avg. open price: $66.84 Current price: $102.01 P/L: +52.62% Sold -22.41% shares Q3 2022	share	2.23%	21.30M	$66.84	$102.01	+52.62%	Sold -22.41% shares Q3 2022
Drug Manufacturers—General Gilead Sciences, Inc. Portfolio share: 2.22% Portfolio value: 21.18M Avg. open price: $67.86 Current price: $87.98 P/L: +29.65% Bought +35.00% shares Q3 2022	share	2.22%	21.18M	$67.86	$87.98	+29.65%	Bought +35.00% shares Q3 2022
Medical Devices Medtronic plc Portfolio share: 2.19% Portfolio value: 20.96M Avg. open price: $90.71 Current price: $78.79 P/L: -13.14% Bought +60.00% shares Q3 2022	share	2.19%	20.96M	$90.71	$78.79	-13.14%	Bought +60.00% shares Q3 2022
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 2.15% Portfolio value: 20.53M Avg. open price: $103.76 Current price: $103.53 P/L: -0.22% Bought +69.29% shares Q3 2022	share	2.15%	20.53M	$103.76	$103.53	-0.22%	Bought +69.29% shares Q3 2022
Medical Instruments & Supplies Becton, Dickinson and Company Portfolio share: 2.10% Portfolio value: 20.05M Avg. open price: $242.83 Current price: $246.21 P/L: +1.39% Bought +88.89% shares Q3 2022	share	2.10%	20.05M	$242.83	$246.21	+1.39%	Bought +88.89% shares Q3 2022
Medical Distribution McKesson Corporation Portfolio share: 2.04% Portfolio value: 19.46M Avg. open price: $192.9 Current price: $382.44 P/L: +98.26% Sold -20.63% shares Q3 2022	share	2.04%	19.46M	$192.9	$382.44	+98.26%	Sold -20.63% shares Q3 2022
Biotechnology Jazz Pharmaceuticals plc Portfolio share: 1.98% Portfolio value: 18.90M Avg. open price: $144.8 Current price: $150.97 P/L: +4.26% Sold -17.81% shares Q3 2022	share	1.98%	18.90M	$144.8	$150.97	+4.26%	Sold -17.81% shares Q3 2022
Drug Manufacturers—General Johnson & Johnson Portfolio share: 1.82% Portfolio value: 17.39M Avg. open price: $157.92 Current price: $178.78 P/L: +13.21% Sold -11.50% shares Q2 2022	share	1.82%	17.39M	$157.92	$178.78	+13.21%	Sold -11.50% shares Q2 2022
Drug Manufacturers—General Pfizer Inc. Portfolio share: 1.71% Portfolio value: 16.29M Avg. open price: $36.22 Current price: $50.73 P/L: +40.06% Sold -35.19% shares Q3 2022	share	1.71%	16.29M	$36.22	$50.73	+40.06%	Sold -35.19% shares Q3 2022
Diagnostics & Research Danaher Corporation Portfolio share: 1.63% Portfolio value: 15.60M Avg. open price: $281.96 Current price: $267.97 P/L: -4.96% Bought +14.81% shares Q3 2022	share	1.63%	15.60M	$281.96	$267.97	-4.96%	Bought +14.81% shares Q3 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 1.63% Portfolio value: 15.54M Avg. open price: $119.15 Current price: $226.4 P/L: +90.02% Sold -42.31% shares Q2 2022	share	1.63%	15.54M	$119.15	$226.4	+90.02%	Sold -42.31% shares Q2 2022
Medical Devices Axonics, Inc. Portfolio share: 1.61% Portfolio value: 15.35M Avg. open price: $33.3 Current price: $67.47 P/L: +102.59% Sold -12.50% shares Q3 2022	share	1.61%	15.35M	$33.3	$67.47	+102.59%	Sold -12.50% shares Q3 2022
Medical Care Facilities Tenet Healthcare Corporation Portfolio share: 1.60% Portfolio value: 15.26M Avg. open price: $66.56 Current price: $44.6 P/L: -32.99% Bought +31.80% shares Q3 2022	share	1.60%	15.26M	$66.56	$44.6	-32.99%	Bought +31.80% shares Q3 2022
Biotechnology BioNTech SE Portfolio share: 1.43% Portfolio value: 13.62M Avg. open price: $156.76 Current price: $166.71 P/L: +6.34% Bought +10.00% shares Q3 2022	share	1.43%	13.62M	$156.76	$166.71	+6.34%	Bought +10.00% shares Q3 2022
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 1.39% Portfolio value: 13.30M Avg. open price: $48.49 Current price: $49.41 P/L: +1.89% Bought +4.76% shares Q3 2022	share	1.39%	13.30M	$48.49	$49.41	+1.89%	Bought +4.76% shares Q3 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 1.39% Portfolio value: 13.26M Avg. open price: $107.92 Current price: $92.75 P/L: -14.06% Bought +3.72% shares Q3 2022	share	1.39%	13.26M	$107.92	$92.75	-14.06%	Bought +3.72% shares Q3 2022
Medical Instruments & Supplies The Cooper Companies, Inc. Portfolio share: 1.34% Portfolio value: 12.82M Avg. open price: $300.75 Current price: $321.56 P/L: +6.92% Bought +26.76% shares Q3 2022	share	1.34%	12.82M	$300.75	$321.56	+6.92%	Bought +26.76% shares Q3 2022
Medical Instruments & Supplies Intuitive Surgical, Inc. Portfolio share: 1.29% Portfolio value: 12.32M Avg. open price: $266.06 Current price: $269.72 P/L: +1.38% Sold -28.57% shares Q3 2022	share	1.29%	12.32M	$266.06	$269.72	+1.38%	Sold -28.57% shares Q3 2022
Biotechnology Harmony Biosciences Holdings, Inc. Portfolio share: 1.29% Portfolio value: 12.32M Avg. open price: $33.46 Current price: $60.91 P/L: +82.03% Sold -8.85% shares Q3 2022	share	1.29%	12.32M	$33.46	$60.91	+82.03%	Sold -8.85% shares Q3 2022
Medical Devices Inspire Medical Systems, Inc. Portfolio share: 1.29% Portfolio value: 12.28M Avg. open price: $197.02 Current price: $234.96 P/L: +19.25% Bought +26.00% shares Q3 2022	share	1.29%	12.28M	$197.02	$234.96	+19.25%	Bought +26.00% shares Q3 2022
Medical Devices Abbott Laboratories Portfolio share: 1.21% Portfolio value: 11.57M Avg. open price: $82.39 Current price: $105.38 P/L: +27.90% Sold -31.18% shares Q3 2022	share	1.21%	11.57M	$82.39	$105.38	+27.90%	Sold -31.18% shares Q3 2022
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 1.00% Portfolio value: 9.55M Avg. open price: $92.55 Current price: $124 P/L: +33.99% Sold -12.63% shares Q3 2022	share	1.00%	9.55M	$92.55	$124	+33.99%	Sold -12.63% shares Q3 2022
Medical Care Facilities HCA Healthcare, Inc. Portfolio share: 0.98% Portfolio value: 9.35M Avg. open price: $121.49 Current price: $235.35 P/L: +93.72% Bought +72.00% shares Q3 2022	share	0.98%	9.35M	$121.49	$235.35	+93.72%	Bought +72.00% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 0.97% Portfolio value: 9.29M Avg. open price: $301.44 Current price: $292.75 P/L: -2.88% N/A Q3 2022	share	0.97%	9.29M	$301.44	$292.75	-2.88%	N/A Q3 2022
Health Information Services Privia Health Group, Inc. Portfolio share: 0.97% Portfolio value: 9.27M Avg. open price: $23.56 Current price: $23.52 P/L: -0.17% Sold -7.67% shares Q3 2022	share	0.97%	9.27M	$23.56	$23.52	-0.17%	Sold -7.67% shares Q3 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 0.96% Portfolio value: 9.16M Avg. open price: $45.6 Current price: $38.12 P/L: -16.40% Sold -8.70% shares Q3 2022	share	0.96%	9.16M	$45.6	$38.12	-16.40%	Sold -8.70% shares Q3 2022
Biotechnology Royalty Pharma plc Portfolio share: 0.95% Portfolio value: 9.09M Avg. open price: $42.04 Current price: $43.01 P/L: +2.31% Bought +43.33% shares Q3 2022	share	0.95%	9.09M	$42.04	$43.01	+2.31%	Bought +43.33% shares Q3 2022
Medical Devices Edwards Lifesciences Corporation Portfolio share: 0.95% Portfolio value: 9.05M Avg. open price: $53.77 Current price: $73.85 P/L: +37.36% Bought +177.78% shares Q3 2022	share	0.95%	9.05M	$53.77	$73.85	+37.36%	Bought +177.78% shares Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 0.91% Portfolio value: 8.73M Avg. open price: $9.62 Current price: $21.89 P/L: +127.55% Bought +46.00% shares Q3 2022	share	0.91%	8.73M	$9.62	$21.89	+127.55%	Bought +46.00% shares Q3 2022
Biotechnology Revance Therapeutics, Inc. Portfolio share: 0.91% Portfolio value: 8.65M Avg. open price: $21.11 Current price: $21.1 P/L: -0.06% Sold -13.78% shares Q3 2022	share	0.91%	8.65M	$21.11	$21.1	-0.06%	Sold -13.78% shares Q3 2022
Biotechnology Immunocore Holdings plc Portfolio share: 0.90% Portfolio value: 8.57M Avg. open price: $34.45 Current price: $58.07 P/L: +68.54% Bought +7.14% shares Q3 2022	share	0.90%	8.57M	$34.45	$58.07	+68.54%	Bought +7.14% shares Q3 2022
Drug Manufacturers—Specialty & Generic Dynavax Technologies Corporation Portfolio share: 0.88% Portfolio value: 8.39M Avg. open price: $8.32 Current price: $12.3 P/L: +47.81% Sold -8.31% shares Q3 2022	share	0.88%	8.39M	$8.32	$12.3	+47.81%	Sold -8.31% shares Q3 2022
Biotechnology Xencor, Inc. Portfolio share: 0.86% Portfolio value: 8.23M Avg. open price: $32.92 Current price: $29.54 P/L: -10.27% Sold -1.97% shares Q3 2022	share	0.86%	8.23M	$32.92	$29.54	-10.27%	Sold -1.97% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 0.85% Portfolio value: 8.10M Avg. open price: $16.83 Current price: $98.48 P/L: +484.98% Sold -60.04% shares Q3 2022	share	0.85%	8.10M	$16.83	$98.48	+484.98%	Sold -60.04% shares Q3 2022
Medical Devices Insulet Corporation Portfolio share: 0.79% Portfolio value: 7.50M Avg. open price: N/A Current price: $302.43 P/L: N/A N/A Q3 2022	share	0.79%	7.50M	N/A	$302.43	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Esperion Therapeutics, Inc. Portfolio share: 0.77% Portfolio value: 7.31M Avg. open price: $30.84 Current price: $7.49 P/L: -75.71% Sold -8.31% shares Q2 2022	share	0.77%	7.31M	$30.84	$7.49	-75.71%	Sold -8.31% shares Q2 2022
Medical Devices Silk Road Medical, Inc Portfolio share: 0.72% Portfolio value: 6.83M Avg. open price: $43.78 Current price: $53.65 P/L: +22.56% Sold -11.43% shares Q3 2022	share	0.72%	6.83M	$43.78	$53.65	+22.56%	Sold -11.43% shares Q3 2022
Health Information Services R1 RCM Inc. Portfolio share: 0.70% Portfolio value: 6.67M Avg. open price: $24.19 Current price: $10.11 P/L: -58.21% Bought +16.31% shares Q3 2022	share	0.70%	6.67M	$24.19	$10.11	-58.21%	Bought +16.31% shares Q3 2022
Biotechnology ImmunoGen, Inc. Portfolio share: 0.68% Portfolio value: 6.53M Avg. open price: $7.38 Current price: $5.43 P/L: -26.43% Sold -8.33% shares Q3 2022	share	0.68%	6.53M	$7.38	$5.43	-26.43%	Sold -8.33% shares Q3 2022
Medical Devices ShockWave Medical, Inc. Portfolio share: 0.61% Portfolio value: 5.86M Avg. open price: $191.78 Current price: $243.11 P/L: +26.77% Sold -71.82% shares Q3 2022	share	0.61%	5.86M	$191.78	$243.11	+26.77%	Sold -71.82% shares Q3 2022
Health Information Services Veeva Systems Inc. Portfolio share: 0.61% Portfolio value: 5.79M Avg. open price: $261.24 Current price: $167.24 P/L: -35.98% Sold -9.21% shares Q3 2022	share	0.61%	5.79M	$261.24	$167.24	-35.98%	Sold -9.21% shares Q3 2022
Drug Manufacturers—Specialty & Generic Intra-Cellular Therapies, Inc. Portfolio share: 0.60% Portfolio value: 5.70M Avg. open price: $15.25 Current price: $54.25 P/L: +255.76% Sold -10.71% shares Q3 2022	share	0.60%	5.70M	$15.25	$54.25	+255.76%	Sold -10.71% shares Q3 2022
Medical Devices Outset Medical, Inc. Portfolio share: 0.55% Portfolio value: 5.28M Avg. open price: $14.86 Current price: $21.42 P/L: +44.15% Bought +88.89% shares Q3 2022	share	0.55%	5.28M	$14.86	$21.42	+44.15%	Bought +88.89% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 0.55% Portfolio value: 5.21M Avg. open price: $90.9 Current price: $121.22 P/L: +33.36% Sold -9.31% shares Q3 2022	share	0.55%	5.21M	$90.9	$121.22	+33.36%	Sold -9.31% shares Q3 2022
Medical Care Facilities agilon health, inc. Portfolio share: 0.53% Portfolio value: 5.06M Avg. open price: $21.83 Current price: $17.7 P/L: -18.92% Bought +54.55% shares Q3 2022	share	0.53%	5.06M	$21.83	$17.7	-18.92%	Bought +54.55% shares Q3 2022
Medical Devices Glaukos Corporation Portfolio share: 0.50% Portfolio value: 4.76M Avg. open price: $45.98 Current price: $45.88 P/L: -0.21% Sold -5.55% shares Q3 2022	share	0.50%	4.76M	$45.98	$45.88	-0.21%	Sold -5.55% shares Q3 2022
Biotechnology Iovance Biotherapeutics, Inc. Portfolio share: 0.50% Portfolio value: 4.76M Avg. open price: $14.97 Current price: $8.03 P/L: -46.36% Sold -3.77% shares Q3 2022	share	0.50%	4.76M	$14.97	$8.03	-46.36%	Sold -3.77% shares Q3 2022
Medical Instruments & Supplies Envista Holdings Corporation Portfolio share: 0.50% Portfolio value: 4.74M Avg. open price: N/A Current price: $33.51 P/L: N/A N/A Q3 2022	share	0.50%	4.74M	N/A	$33.51	N/A	N/A Q3 2022
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 0.46% Portfolio value: 4.38M Avg. open price: N/A Current price: $226.95 P/L: N/A N/A Q3 2022	share	0.46%	4.38M	N/A	$226.95	N/A	N/A Q3 2022
Medical Devices ViewRay, Inc. Portfolio share: 0.45% Portfolio value: 4.29M Avg. open price: $5.6 Current price: $4.63 P/L: -17.28% Bought +36.05% shares Q2 2022	share	0.45%	4.29M	$5.6	$4.63	-17.28%	Bought +36.05% shares Q2 2022
Biotechnology MeiraGTx Holdings plc Portfolio share: 0.42% Portfolio value: 4.03M Avg. open price: $14.66 Current price: $6.49 P/L: -55.77% Bought +11.01% shares Q3 2022	share	0.42%	4.03M	$14.66	$6.49	-55.77%	Bought +11.01% shares Q3 2022
Health Information Services Progyny, Inc. Portfolio share: 0.42% Portfolio value: 4.00M Avg. open price: $56 Current price: $34.07 P/L: -39.16% Sold -10.00% shares Q2 2022	share	0.42%	4.00M	$56	$34.07	-39.16%	Sold -10.00% shares Q2 2022
Biotechnology G1 Therapeutics, Inc. Portfolio share: 0.41% Portfolio value: 3.94M Avg. open price: $22.06 Current price: $6.17 P/L: -72.03% Bought +17.04% shares Q3 2022	share	0.41%	3.94M	$22.06	$6.17	-72.03%	Bought +17.04% shares Q3 2022
Medical Instruments & Supplies West Pharmaceutical Services, Inc. Portfolio share: 0.41% Portfolio value: 3.91M Avg. open price: N/A Current price: $239.44 P/L: N/A N/A Q3 2022	share	0.41%	3.91M	N/A	$239.44	N/A	N/A Q3 2022
Health Information Services Teladoc Health, Inc. Portfolio share: 0.40% Portfolio value: 3.85M Avg. open price: $143.76 Current price: $27.08 P/L: -81.16% Bought +52.94% shares Q3 2022	share	0.40%	3.85M	$143.76	$27.08	-81.16%	Bought +52.94% shares Q3 2022
Diagnostics & Research Natera, Inc. Portfolio share: 0.39% Portfolio value: 3.75M Avg. open price: N/A Current price: $40.39 P/L: N/A N/A Q3 2022	share	0.39%	3.75M	N/A	$40.39	N/A	N/A Q3 2022
Healthcare Plans Alignment Healthcare, Inc. Portfolio share: 0.38% Portfolio value: 3.64M Avg. open price: N/A Current price: $12.95 P/L: N/A N/A Q3 2022	share	0.38%	3.64M	N/A	$12.95	N/A	N/A Q3 2022
Biotechnology Sangamo Therapeutics, Inc. Portfolio share: 0.38% Portfolio value: 3.6M Avg. open price: $15.79 Current price: $3.54 P/L: -77.58% Bought +17.14% shares Q3 2022	share	0.38%	3.6M	$15.79	$3.54	-77.58%	Bought +17.14% shares Q3 2022
Diagnostics & Research Olink Holding AB (publ) Portfolio share: 0.37% Portfolio value: 3.56M Avg. open price: $15.2 Current price: $22 P/L: +44.74% Bought +38.85% shares Q3 2022	share	0.37%	3.56M	$15.2	$22	+44.74%	Bought +38.85% shares Q3 2022
Biotechnology Allogene Therapeutics, Inc. Portfolio share: 0.37% Portfolio value: 3.50M Avg. open price: N/A Current price: $9.37 P/L: N/A Sold -2.86% shares Q3 2022	share	0.37%	3.50M	N/A	$9.37	N/A	Sold -2.86% shares Q3 2022
Health Information Services Phreesia, Inc. Portfolio share: 0.36% Portfolio value: 3.41M Avg. open price: $46.68 Current price: $28.04 P/L: -39.93% Bought +66.67% shares Q3 2022	share	0.36%	3.41M	$46.68	$28.04	-39.93%	Bought +66.67% shares Q3 2022
Drug Manufacturers—Specialty & Generic Alkermes plc Portfolio share: 0.36% Portfolio value: 3.40M Avg. open price: $47.72 Current price: $25.51 P/L: -46.54% Sold -16.67% shares Q2 2022	share	0.36%	3.40M	$47.72	$25.51	-46.54%	Sold -16.67% shares Q2 2022
Diagnostics & Research Guardant Health, Inc. Portfolio share: 0.34% Portfolio value: 3.21M Avg. open price: $86.86 Current price: $51.95 P/L: -40.19% Sold -31.58% shares Q3 2022	share	0.34%	3.21M	$86.86	$51.95	-40.19%	Sold -31.58% shares Q3 2022
Diagnostics & Research Exact Sciences Corporation Portfolio share: 0.28% Portfolio value: 2.64M Avg. open price: $129.26 Current price: $45.55 P/L: -64.76% Sold -30.91% shares Q1 2022	share	0.28%	2.64M	$129.26	$45.55	-64.76%	Sold -30.91% shares Q1 2022
Biotechnology Intellia Therapeutics, Inc. Portfolio share: 0.28% Portfolio value: 2.63M Avg. open price: N/A Current price: $42.01 P/L: N/A N/A Q1 2022	share	0.28%	2.63M	N/A	$42.01	N/A	N/A Q1 2022
Biotechnology Nkarta, Inc. Portfolio share: 0.26% Portfolio value: 2.52M Avg. open price: N/A Current price: $8.15 P/L: N/A N/A Q2 2022	share	0.26%	2.52M	N/A	$8.15	N/A	N/A Q2 2022
Biotechnology Phathom Pharmaceuticals, Inc. Portfolio share: 0.26% Portfolio value: 2.49M Avg. open price: $22.83 Current price: $11.07 P/L: -51.51% Bought +26.31% shares Q1 2022	share	0.26%	2.49M	$22.83	$11.07	-51.51%	Bought +26.31% shares Q1 2022
Biotechnology Arvinas, Inc. Portfolio share: 0.26% Portfolio value: 2.48M Avg. open price: N/A Current price: $39.53 P/L: N/A N/A Q2 2022	share	0.26%	2.48M	N/A	$39.53	N/A	N/A Q2 2022
Medical Instruments & Supplies NovoCure Limited Portfolio share: 0.26% Portfolio value: 2.47M Avg. open price: $85.65 Current price: $78 P/L: -8.93% Sold -41.67% shares Q3 2022	share	0.26%	2.47M	$85.65	$78	-8.93%	Sold -41.67% shares Q3 2022
Biotechnology Ionis Pharmaceuticals, Inc. Portfolio share: 0.23% Portfolio value: 2.21M Avg. open price: N/A Current price: $38.98 P/L: N/A Sold -29.58% shares Q2 2022	share	0.23%	2.21M	N/A	$38.98	N/A	Sold -29.58% shares Q2 2022
Biotechnology Nektar Therapeutics Portfolio share: 0.22% Portfolio value: 2.06M Avg. open price: $43.08 Current price: $2.97 P/L: -93.11% Sold -10.41% shares Q2 2022	share	0.22%	2.06M	$43.08	$2.97	-93.11%	Sold -10.41% shares Q2 2022
Health Information Services 10x Genomics, Inc. Portfolio share: 0.21% Portfolio value: 2.03M Avg. open price: N/A Current price: $36.57 P/L: N/A N/A Q3 2022	share	0.21%	2.03M	N/A	$36.57	N/A	N/A Q3 2022
Health Information Services Health Catalyst, Inc. Portfolio share: 0.17% Portfolio value: 1.58M Avg. open price: $46.77 Current price: $10.84 P/L: -76.82% Sold -25.00% shares Q1 2022	share	0.17%	1.58M	$46.77	$10.84	-76.82%	Sold -25.00% shares Q1 2022
Medical Instruments & Supplies Stereotaxis, Inc. Portfolio share: 0.16% Portfolio value: 1.49M Avg. open price: $7.32 Current price: $2.23 P/L: -69.55% Sold -0.33% shares Q1 2022	share	0.16%	1.49M	$7.32	$2.23	-69.55%	Sold -0.33% shares Q1 2022
Biotechnology ESSA Pharma Inc. Portfolio share: 0.14% Portfolio value: 1.35M Avg. open price: $24.69 Current price: $3.47 P/L: -85.95% Sold -8.74% shares Q2 2022	share	0.14%	1.35M	$24.69	$3.47	-85.95%	Sold -8.74% shares Q2 2022
Biotechnology Rigel Pharmaceuticals, Inc. Portfolio share: 0.09% Portfolio value: 893K Avg. open price: $2.71 Current price: $0.95 P/L: -65.00% Sold -4.12% shares Q2 2022	share	0.09%	893K	$2.71	$0.95	-65.00%	Sold -4.12% shares Q2 2022
Medical Devices Rapid Micro Biosystems, Inc. Portfolio share: 0.09% Portfolio value: 876K Avg. open price: $10.68 Current price: $1.88 P/L: -82.40% Bought +52.99% shares Q1 2022	share	0.09%	876K	$10.68	$1.88	-82.40%	Bought +52.99% shares Q1 2022
Drug Manufacturers—Specialty & Generic Aerie Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $32.78 Current price: $15.25 P/L: -53.47% Sold -100.00% shares Q3 2022	share	0.00%	0	$32.78	$15.25	-53.47%	Sold -100.00% shares Q3 2022
Medical Devices Align Technology, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $662.22 Current price: $187.96 P/L: -71.62% Sold -100.00% shares Q3 2022	share	0.00%	0	$662.22	$187.96	-71.62%	Sold -100.00% shares Q3 2022
Health Information Services 1Life Healthcare, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $31.16 Current price: $16.74 P/L: -46.28% Sold -100.00% shares Q3 2022	share	0.00%	0	$31.16	$16.74	-46.28%	Sold -100.00% shares Q3 2022
Biotechnology Myovant Sciences Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $19.83 Current price: $26.81 P/L: +35.20% Sold -100.00% shares Q3 2022	share	0.00%	0	$19.83	$26.81	+35.20%	Sold -100.00% shares Q3 2022

Showing TOP 94 RHENMAN & PARTNERS ASSET MANAGEMENT AB's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of RHENMAN & PARTNERS ASSET MANAGEMENT AB?

The biggest position of the RHENMAN & PARTNERS ASSET MANAGEMENT AB is Eli Lilly and Company (LLY) with 3.68% portfolio share worth of 35.12M US dollars.

Top 5 RHENMAN & PARTNERS ASSET MANAGEMENT AB's holdings represent 15.96% of the portfolio:

Eli Lilly and Company (LLY) – 3.68%
UnitedHealth Group Incorporated (UNH) – 3.19%
Boston Scientific Corporation (BSX) – 3.14%
Vertex Pharmaceuticals Incorporated (VRTX) – 3.14%
Thermo Fisher Scientific Inc. (TMO) – 2.83%

Who is the portfolio manager of RHENMAN & PARTNERS ASSET MANAGEMENT AB?

The portfolio manager of the RHENMAN & PARTNERS ASSET MANAGEMENT AB is .

What is the total asset value of the RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio?

RHENMAN & PARTNERS ASSET MANAGEMENT AB total asset value (portfolio value) is 955.01M US dollars.

Who is ?

is the portfolio manager of the RHENMAN & PARTNERS ASSET MANAGEMENT AB.

What is (RHENMAN & PARTNERS ASSET MANAGEMENT AB) fund performance?

RHENMAN & PARTNERS ASSET MANAGEMENT AB's quarterly performance is +1.38%, annualy -5.73%. In the past 3 years, the value of 's portfolio has increased by +53%. In the past 5 years, the value of the portfolio has increased by +62%.

What is the RHENMAN & PARTNERS ASSET MANAGEMENT AB CIK?

RHENMAN & PARTNERS ASSET MANAGEMENT AB's Central Index Key is 0001599882 .

RHENMAN & PARTNERS ASSET MANAGEMENT AB Holdings

RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio value:

RHENMAN & PARTNERS ASSET MANAGEMENT AB quarter portfolio value change:

RHENMAN & PARTNERS ASSET MANAGEMENT AB 1 year portfolio value change:

RHENMAN & PARTNERS ASSET MANAGEMENT AB 3 years portfolio value change:

RHENMAN & PARTNERS ASSET MANAGEMENT AB 5 years portfolio value change: